{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:39:50Z","timestamp":1789663190986,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The aim of this study was to investigate the relationship of insulin-like growth factor-1 (IGF-1) and mild subclinical hypothyroidism (MSH) in obese boys and to assess whether the presence of MSH exacerbates cardiovascular risk factors in obesity. This study collected cross-sectional dataset covering 141 obese boys and 47 healthy non-obese boys. The obese group was further subdivided into two groups based on their serum Thyroid Stimulating Hormone (TSH) levels: the MSH group (n\u2009=\u200947) and the non-MSH group (n\u2009=\u200994). The MSH group exhibited significantly lower IGF-1 standard deviation score (IGF-1 SDS) and significantly higher Body Mass Index standard deviation score (BMI SDS) compared to the non-MSH group. Additionally, the MSH group demonstrated elevated triglycerides (TG) and gamma-glutamyl transferase (GGT) levels relative to the non-MSH group, and the incidence of non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) were also higher in the MSH group than in the non-MSH group. The results of multivariable logistic regression analysis indicated that lower IGF-1 SDS and higher BMI SDS are strongly associated with MSH in obese boys, independently of systolic blood pressure (SBP), diastolic blood pressure (DBP), alanine aminotransferase (ALT), GGT and uric acid. These findings underscore the clinical utility of IGF-1 SDS and BMI SDS as potential biomarkers for identifying MSH-related cardiovascular risks in obese pediatric populations, warranting targeted screening and intervention strategies.<\/jats:p>","DOI":"10.1038\/s41598-025-02084-x","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:07:37Z","timestamp":1747375657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of insulin-like growth factor 1 and metabolic parameters with mild subclinical hypothyroidism in obese boys"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiang","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2084_CR1","unstructured":"Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 16, 1027\u20131050 (2024)."},{"key":"2084_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","volume":"10","author":"H Jebeile","year":"2022","unstructured":"Jebeile, H. et al. Obesity in children and adolescents: Epidemiology, causes, assessment, and management. Lancet Diabet. Endocrinol. 10, 351\u2013365 (2022).","journal-title":"Lancet Diabet. Endocrinol."},{"key":"2084_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/nu16010087","volume":"16","author":"B Biondi","year":"2023","unstructured":"Biondi, B. Subclinical hypothyroidism in patients with obesity and metabolic syndrome: A narrative review. Nutrients 16, 87 (2023).","journal-title":"Nutrients"},{"key":"2084_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cca.2011.11.013","volume":"413","author":"L Pacifico","year":"2012","unstructured":"Pacifico, L. et al. Thyroid function in childhood obesity and metabolic comorbidity. Clin. Chim. Acta 413, 396\u2013405 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"2084_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/jpc.13926","volume":"54","author":"HY Jin","year":"2018","unstructured":"Jin, H. Y. Prevalence of subclinical hypothyroidism in obese children or adolescents and association between thyroid hormone and the components of metabolic syndrome. J. Paediatr. Child Health 54, 975\u2013980 (2018).","journal-title":"J. Paediatr. Child Health"},{"key":"2084_CR6","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EJE-20-0051","volume":"183","author":"M Salerno","year":"2020","unstructured":"Salerno, M. et al. Management of endocrine disease subclinical hypothyroidism in children. Eur. J. Endocrinol. 183, R13-r28 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"2084_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000362597","volume":"3","author":"J Lazarus","year":"2014","unstructured":"Lazarus, J. et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur. Thyroid J. 3, 76\u201394 (2014).","journal-title":"Eur. Thyroid J."},{"key":"2084_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/ijpo.12112","volume":"11","author":"AJ Krause","year":"2016","unstructured":"Krause, A. J. et al. Associations between adiposity and indicators of thyroid status in children and adolescents. Pediatr. Obes. 11, 551\u2013558 (2016).","journal-title":"Pediatr. Obes."},{"key":"2084_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4183\/aeb.2020.334","volume":"16","author":"N Akici","year":"2020","unstructured":"Akici, N. et al. Atherogenic indices in the assessment of cardiovascular disease risk in children with obesity and subclinical hypothyroidism. Acta Endocrinol. (Buchar.) 16, 334\u2013338 (2020).","journal-title":"Acta Endocrinol. (Buchar.)"},{"key":"2084_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s12020-019-01942-9","volume":"65","author":"MK Lee","year":"2019","unstructured":"Lee, M. K. et al. Evaluation of the relationship of subclinical hypothyroidism with metabolic syndrome and its components in adolescents: A population-based study. Endocrine 65, 608\u2013615 (2019).","journal-title":"Endocrine"},{"key":"2084_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5152\/TurkArchPediatr.2022.21263","volume":"57","author":"D \u00d6zalp K\u0131z\u0131lay","year":"2022","unstructured":"\u00d6zalp K\u0131z\u0131lay, D. & Uysal, A. \u015e. Isolated hyperthyrotropinemia adversely influences lipid metabolism in children and adolescents with obesity. Turk. Arch. Pediatr. 57, 300\u2013309 (2022).","journal-title":"Turk. Arch. Pediatr."},{"key":"2084_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12098-020-03463-0","volume":"88","author":"R Patel","year":"2021","unstructured":"Patel, R. et al. Metabolic impact of subclinical hypothyroidism in obese children and adolescents. Indian J. Pediatr. 88, 437\u2013440 (2021).","journal-title":"Indian J. Pediatr."},{"key":"2084_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jped.2016.01.011","volume":"92","author":"LL Souza","year":"2016","unstructured":"Souza, L. L. et al. Serum TSH levels are associated with cardiovascular risk factors in overweight and obese adolescents. J. Pediatr. (Rio J.) 92, 532\u2013538 (2016).","journal-title":"J. Pediatr. (Rio J.)"},{"key":"2084_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.15557\/JoU.2018.0043","volume":"18","author":"M Rumi\u0144ska","year":"2018","unstructured":"Rumi\u0144ska, M. et al. Serum TSH level in obese children and its correlations with atherogenic lipid indicators and carotid intima media thickness. J. Ultrason. 18, 296\u2013301 (2018).","journal-title":"J. Ultrason."},{"key":"2084_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12944-016-0275-7","volume":"15","author":"S Liang","year":"2016","unstructured":"Liang, S. et al. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: A cross-sectional study. Lipids Health Dis. 15, 112 (2016).","journal-title":"Lipids Health Dis."},{"key":"2084_CR16","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/nu15081849","volume":"15","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Association of body mass index with insulin-like growth factor-1 levels among 3227 Chinese children aged 2\u201318 years. Nutrients 15, 1849 (2023).","journal-title":"Nutrients"},{"key":"2084_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/apa.13685","volume":"106","author":"S Liang","year":"2017","unstructured":"Liang, S. et al. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents. Acta Paediatr. 106, 298\u2013303 (2017).","journal-title":"Acta Paediatr."},{"key":"2084_CR18","doi-asserted-by":"publisher","first-page":"6680316","DOI":"10.1155\/2021\/6680316","volume":"2021","author":"J Kuang","year":"2021","unstructured":"Kuang, J. et al. Reduced insulin-like growth factor 1 is associated with insulin resistance in obese prepubertal boys. Biomed. Res. Int. 2021, 6680316 (2021).","journal-title":"Biomed. Res. Int."},{"key":"2084_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ghir.2008.11.003","volume":"19","author":"F Akin","year":"2009","unstructured":"Akin, F. et al. Growth hormone\/insulin-like growth factor axis in patients with subclinical thyroid dysfunction. Growth Horm. IGF Res. 19, 252\u2013255 (2009).","journal-title":"Growth Horm. IGF Res."},{"key":"2084_CR20","doi-asserted-by":"publisher","first-page":"306750","DOI":"10.1155\/2013\/306750","volume":"2013","author":"C Eke Koyuncu","year":"2013","unstructured":"Eke Koyuncu, C. et al. Serum resistin and insulin-like growth factor-1 levels in patients with hypothyroidism and hyperthyroidism. J. Thyroid Res. 2013, 306750 (2013).","journal-title":"J. Thyroid Res."},{"key":"2084_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1515\/jpem-2016-0359","volume":"30","author":"RK Marwaha","year":"2017","unstructured":"Marwaha, R. K. et al. Assessment of insulin-like growth factor-1 and IGF binding protein-3 in healthy Indian girls from Delhi and their correlation with age, pubertal status, obesity and thyroid hormonal status. J. Pediatr. Endocrinol. Metab. 30, 739\u2013747 (2017).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"2084_CR22","first-page":"6","volume":"47","author":"H Liang","year":"2009","unstructured":"Liang, H. et al. Standardized growth curves for height and weight of children and adolescents aged 0\u201318 years in China. Chin. J. Pediatr. 47, 6 (2009).","journal-title":"Chin. J. Pediatr."},{"key":"2084_CR23","first-page":"18","volume":"49","author":"Chinese Society of Hepatology, Fatty Liver Disease and Alcoholic Liver Disease Group","year":"2010","unstructured":"Chinese Society of Hepatology, Fatty Liver Disease and Alcoholic Liver Disease Group. Guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease. Chin J Hepatol. 49, 18\u201320 (2010).","journal-title":"Chin J Hepatol."},{"key":"2084_CR24","first-page":"3","volume":"50","author":"JF Fu","year":"2012","unstructured":"Fu, J. F. et al. Definition and prevention recommendations for metabolic syndrome in Chinese children and adolescents. Chin. J. Pediatr. 50, 3 (2012).","journal-title":"Chin. J. Pediatr."},{"key":"2084_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner, J. M. & Whitehouse, R. H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch. Dis. Child. 51, 170\u2013179 (1976).","journal-title":"Arch. Dis. Child."},{"key":"2084_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.eprac.2022.04.004","volume":"28","author":"B Cao","year":"2022","unstructured":"Cao, B. et al. Pediatric continuous reference intervals of serum insulin-like growth factor 1 levels in a healthy Chinese children population - based on PRINCE study. Endocr. Pract. 28, 696\u2013702 (2022).","journal-title":"Endocr. Pract."},{"key":"2084_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"2084_CR28","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.3390\/molecules190811178","volume":"19","author":"YJ Chang","year":"2014","unstructured":"Chang, Y. J. et al. Effects of subacute hypothyroidism on metabolism and growth-related molecules. Molecules 19, 11178\u201311195 (2014).","journal-title":"Molecules"},{"key":"2084_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000054466","volume":"70","author":"L Boulanger","year":"1999","unstructured":"Boulanger, L. et al. Development of a site-directed polyclonal antibody against the pituitary growth hormone-releasing hormone receptor and its use to estimate GHRH receptor concentration in normal and hypothyroid rats. Neuroendocrinology 70, 117\u2013127 (1999).","journal-title":"Neuroendocrinology"},{"key":"2084_CR30","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.3390\/molecules25173912","volume":"25","author":"K Adamczewska","year":"2020","unstructured":"Adamczewska, K. et al. Strong positive correlation between TSH and ghrelin in euthyroid non-growth hormone-deficient children with short stature. Molecules 25, 3912 (2020).","journal-title":"Molecules"},{"key":"2084_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0167-0115(00)00145-2","volume":"92","author":"LM Seoane","year":"2000","unstructured":"Seoane, L. M. et al. Regulation of in vivo TSH secretion by leptin. Regul. Pept. 92, 25\u201329 (2000).","journal-title":"Regul. Pept."},{"key":"2084_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/oby.2000.83","volume":"8","author":"BC Villafuerte","year":"2000","unstructured":"Villafuerte, B. C. et al. Expressions of leptin and insulin-like growth factor-I are highly correlated and region-specific in adipose tissue of growing rats. Obes. Res. 8, 646\u2013655 (2000).","journal-title":"Obes. Res."},{"key":"2084_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.727004","volume":"12","author":"A Rahman","year":"2021","unstructured":"Rahman, A. et al. Profiling of insulin-like growth factor binding proteins (IGFBPs) in obesity and their association With Ox-LDL and Hs-CRP in adolescents. Front. Endocrinol. (Lausanne) 12, 727004 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2084_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.arcmed.2016.10.007","volume":"47","author":"JH G\u00f3mez-Zamudio","year":"2016","unstructured":"G\u00f3mez-Zamudio, J. H. et al. High thyroid-stimulating hormone levels increase proinflammatory and cardiovascular markers in patients with extreme obesity. Arch. Med. Res. 47, 476\u2013482 (2016).","journal-title":"Arch. Med. Res."},{"issue":"2","key":"2084_CR35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1210\/endo.132.2.7678799","volume":"132","author":"K N\u00e4nt\u00f6-Salonen","year":"1993","unstructured":"N\u00e4nt\u00f6-Salonen, K., Muller, H. L., Hoffman, A. R., Vu, T. H. & Rosenfeld, R. G. Mechanisms of thyroid hormone action on the insulin-like growth factor system: All thyroid hormone effects are not growth hormone mediated. Endocrinology 132(2), 781\u2013788 (1993).","journal-title":"Endocrinology"},{"key":"2084_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.653627","volume":"12","author":"TJ Smith","year":"2021","unstructured":"Smith, T. J. Insulin-like growth factor pathway and the thyroid. Front. Endocrinol. (Lausanne) 12, 653627 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2084_CR37","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s40618-023-02041-3","volume":"46","author":"A Di Sessa","year":"2023","unstructured":"Di Sessa, A. et al. Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity. J. Endocrinol. Invest. 46, 1835\u20131842 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"2084_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1365-2362.1998.00274.x","volume":"28","author":"XQ Liu","year":"1998","unstructured":"Liu, X. Q. et al. Effect of thyroid hormone on plasma apolipoproteins and ApoA- and ApoB-containing lipoprotein particles. Eur. J. Clin. Invest. 28, 266\u2013270 (1998).","journal-title":"Eur. J. Clin. Invest."},{"key":"2084_CR39","first-page":"1","volume":"71","author":"R Ganga","year":"2023","unstructured":"Ganga, R. et al. To assess non alcoholic fatty liver disease in patients with clinical and subclinical hypothyroidism. J. Assoc. Phys. India 71, 1 (2023).","journal-title":"J. Assoc. Phys. India"},{"key":"2084_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.dld.2018.08.012","volume":"50","author":"Z Guo","year":"2018","unstructured":"Guo, Z. et al. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis. Dig. Liver Dis. 50, 1153\u20131162 (2018).","journal-title":"Dig. Liver Dis."},{"key":"2084_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025738","volume":"100","author":"X Zeng","year":"2021","unstructured":"Zeng, X. et al. The relationship between non-alcoholic fatty liver disease and hypothyroidism: A systematic review and meta-analysis. Medicine (Baltimore) 100, e25738 (2021).","journal-title":"Medicine (Baltimore)"},{"key":"2084_CR42","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e137","volume":"36","author":"SY Choi","year":"2021","unstructured":"Choi, S. Y. et al. Severe phenotype of non-alcoholic fatty liver disease in pediatric patients with subclinical hypothyroidism: A retrospective multicenter study from Korea. J. Korean Med. Sci. 36, e137 (2021).","journal-title":"J. Korean Med. Sci."},{"key":"2084_CR43","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/jgh.15871","volume":"37","author":"Y Ha","year":"2022","unstructured":"Ha, Y. et al. Gamma-glutamyl transpeptidase dynamics as a biomarker for advanced fibrosis in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 37, 1624\u20131632 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2084_CR44","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/thy.2010.0180","volume":"20","author":"NS Nader","year":"2010","unstructured":"Nader, N. S. et al. Relationships between thyroid function and lipid status or insulin resistance in a pediatric population. Thyroid 20, 1333\u20131339 (2010).","journal-title":"Thyroid"},{"key":"2084_CR45","doi-asserted-by":"publisher","first-page":"15476","DOI":"10.1038\/s41598-019-51963-7","volume":"9","author":"CG Ma","year":"2019","unstructured":"Ma, C. G. & Shim, Y. S. Association of thyroid-stimulating hormone and thyroid hormones with cardiometabolic risk factors in euthyroid children and adolescents aged 10\u201318 years: A population-based study. Sci. Rep. 9, 15476 (2019).","journal-title":"Sci. Rep."},{"key":"2084_CR46","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1089\/thy.2016.0055","volume":"26","author":"TN Le","year":"2016","unstructured":"Le, T. N., Celi, F. S. & Wickham, E. P. 3rd. Thyrotropin levels are associated with cardiometabolic risk factors in euthyroid adolescents. Thyroid 26, 1441\u20131449 (2016).","journal-title":"Thyroid"},{"key":"2084_CR47","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1210\/clinem\/dgaa900","volume":"106","author":"X Chen","year":"2021","unstructured":"Chen, X., Deng, S., Sena, C., Zhou, C. & Thaker, V. V. Relationship of TSH levels with cardiometabolic risk factors in US youth and reference percentiles for thyroid function. J. Clin. Endocrinol. Metab. 106, e1221\u2013e1230 (2021).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02084-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:03:10Z","timestamp":1747378990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02084-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study was approved by the institutional research ethics committee of the Second Hospital of Shandong University (2019-216-k-193).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17017"}}